NLN
Neurolysin, mitochondrial
Also known as: AGTBP, KIAA1226, NEUL_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BYT8
- Gene
- NLN
- Ensembl
- ENSG00000123213
- Chromosome
- 5
- Canonical length
- 704 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
This gene encodes a member of the metallopeptidase M3 protein family that cleaves neurotensin at the Pro10-Tyr11 bond, leading to the formation of neurotensin(1-10) and neurotensin(11-13). The encoded protein is likely involved in the termination of the neurotensinergic signal in the central nervous system and in the gastrointestinal tract.[provided by RefSeq, Jun 2010]
Canonical amino-acid sequenceUniProt
704 residues, UniProt reviewed canonical sequence.
>Q9BYT8|NLN
1 MIARCLLAVR SLRRVGGSRI LLRMTLGREV MSPLQAMSSY TVAGRNVLRW DLSPEQIKTR
61 TEELIVQTKQ VYDAVGMLGI EEVTYENCLQ ALADVEVKYI VERTMLDFPQ HVSSDKEVRA
121 ASTEADKRLS RFDIEMSMRG DIFERIVHLQ ETCDLGKIKP EARRYLEKSI KMGKRNGLHL
181 PEQVQNEIKS MKKRMSELCI DFNKNLNEDD TFLVFSKAEL GALPDDFIDS LEKTDDDKYK
241 ITLKYPHYFP VMKKCCIPET RRRMEMAFNT RCKEENTIIL QQLLPLRTKV AKLLGYSTHA
301 DFVLEMNTAK STSRVTAFLD DLSQKLKPLG EAEREFILNL KKKECKDRGF EYDGKINAWD
361 LYYYMTQTEE LKYSIDQEFL KEYFPIEVVT EGLLNTYQEL LGLSFEQMTD AHVWNKSVTL
421 YTVKDKATGE VLGQFYLDLY PREGKYNHAA CFGLQPGCLL PDGSRMMAVA ALVVNFSQPV
481 AGRPSLLRHD EVRTYFHEFG HVMHQICAQT DFARFSGTNV ETDFVEVPSQ MLENWVWDVD
541 SLRRLSKHYK DGSPIADDLL EKLVASRLVN TGLLTLRQIV LSKVDQSLHT NTSLDAASEY
601 AKYCSEILGV AATPGTNMPA TFGHLAGGYD GQYYGYLWSE VFSMDMFYSC FKKEGIMNPE
661 VGMKYRNLIL KPGGSLDGMD MLHNFLKREP NQKAFLMSRG LHAPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NLN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 9.3 nTPM
Expression across tissuesHPA
Tissue
- liver: 9.3 nTPM
- skeletal muscle: 8.3 nTPM
- tongue: 6.1 nTPM
- spinal cord: 5.5 nTPM
- cerebral cortex: 4.6 nTPM
- midbrain: 4.2 nTPM
Single-cell type
- hofbauer cells: 71 nCPM
- retinal ganglion cells: 66 nCPM
- enterocytes: 63 nCPM
- myosatellite cells: 60 nCPM
- alveolar cells type 1: 60 nCPM
- other brain neurons: 60 nCPM
Immune cell
- intermediate monocyte: 3.3 nTPM
- classical monocyte: 2.6 nTPM
- non-classical monocyte: 2.3 nTPM
- myeloid DC: 2.2 nTPM
- total PBMC: 1 nTPM
- NK-cell: 0.5 nTPM
Brain region
- cerebral cortex: 11 nTPM
- white matter: 11 nTPM
- medulla oblongata: 9.5 nTPM
- pons: 9.4 nTPM
- thalamus: 9.2 nTPM
- basal ganglia: 9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.25
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- peptide metabolic process
- proteolysis
- regulation of gluconeogenesis
- regulation of skeletal muscle fiber differentiation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NLN as an antibody target. Whether an autoantibody or antibody against NLN could matter depends on whether native NLN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NLN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NLN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...